LEAWOOD, Kan., May 16, 2017 /PRNewswire/ -- Aratana
Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company
focused on the licensing, development and commercialization of
innovative therapeutics for dogs and cats, plans to present at
three upcoming investor conferences, including:
2017 Stifel Dental and Veterinary
Conference in New York City
Wednesday, May 31 at 3:35 p.m. ET
Listen to the Stifel webcast
Jefferies 2017 Global Healthcare
Conference in New York City
Wednesday, June 7, 2017 at
3:00 p.m. ET
Listen to the Jefferies webcast
William
Blair 2017 Growth Stock Conference in Chicago
Wednesday, June 14, 2017 at
9:40 a.m. ET
Listen to the William Blair webcast
Interested parties may listen live or access the audio link
for up to 90 days after the meeting. Presentation slides from the
conference will also be available in the Aratana Investor
Room.
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on licensing, developing and
commercializing innovative therapeutics for dogs and cats. Aratana
believes that it can leverage the investment in the human
biopharmaceutical industry to bring therapeutics to dogs and cats
in a capital and time efficient manner. The company's pipeline
includes therapeutic candidates for the potential treatment of
pain, inappetence, viral diseases, allergy, cancer and other
serious medical conditions. Aratana believes the development and
commercialization of these therapeutics will permit veterinarians
and pet owners to manage pets' medical needs safely and
effectively, resulting in longer and improved quality of life for
pets. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel
Reiff
rreiff@aratana.com
(913) 353-1050
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-participate-at-three-upcoming-investment-conferences-300457700.html
SOURCE Aratana Therapeutics, Inc.